Understanding Elevated Lipoprotein(a): A Focus on Cardiovascular Risk and Screening Recommendations
A Real-World Study of Patients With ASCVD Demonstrates Prevalence of High LDL-C, Demographic Disparities, and Underutilization of Lipid-Lowering Therapy
Exploring Patterns in Lp(a) Testing and Lipid-Lowering Therapy Prescription Across 5 Major US Health Systems in Patients With Atherosclerotic Cardiovascular Disease
Insights Into Lipoprotein(a) Screening Trends: Analysis of a Comprehensive US Health Care Dataset
Lp(a): Evidence of a Link to Major Adverse Cardiovascular Events
Elevated Lipoprotein(a) Increases Cardiovascular Risk Independently of SMuRFs
Examining Low Rates of Real-World Lp(a) Testing: Insights From a Decade-Long Cohort Study in a Diverse Health System
Prospective Atherosclerosis Risk in Communities (ARIC) Study Connects Differences in Lipoprotein(a) With Racial Disparities in Atherosclerotic Cardiovascular Disease